Clinical

Dataset Information

0

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy


ABSTRACT: This pilot research trial studies telomere length in predicting toxicity in older patients with stage III-IV colorectal cancer undergoing chemotherapy. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and predict how well patients will respond to treatment.

DISEASE(S): Stage Iv Colon Cancer,Adenocarcinoma,Stage Iv Rectal Cancer,Signet Ring Adenocarcinoma Of The Rectum,Stage Iiia Rectal Cancer,Stage Iiib Rectal Cancer,Stage Iiib Colon Cancer,Stage Iiic Colon Cancer,Rectal Neoplasms,Cystadenocarcinoma,Stage Iiic Rectal Cancer,Signet Ring Adenocarcinoma Of The Colon,Adenocarcinoma, Mucinous,Mucinous Adenocarcinoma Of The Colon,Colonic Neoplasms,Stage Iiia Colon Cancer,Mucinous Adenocarcinoma Of The Rectum

PROVIDER: 2150968 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-07-31 | GSE235529 | GEO
2015-09-01 | E-GEOD-67983 | biostudies-arrayexpress
| 2051618 | ecrin-mdr-crc
2015-09-01 | GSE67983 | GEO
2020-03-01 | GSE126308 | GEO
| PRJNA521520 | ENA
2024-07-12 | GSE261277 | GEO
| 2098259 | ecrin-mdr-crc
| 2121491 | ecrin-mdr-crc
2018-09-06 | E-MTAB-5793 | biostudies-arrayexpress